AN2 Therapeutics, Inc.ANTXNASDAQ
Loading
EBITDA Over TimeContracting
Percentile Rank17
Studio
Year-over-Year Change

Earnings before interest, taxes, depreciation, and amortization

Percentile
P17
Within normal range
vs 2Y Ago
-7.8x
Contraction
Streak
2 yr
Consecutive declineContracting
PeriodValueYoY Change
TTM$-38.11M-1278.8%
2024$3.23M-34.1%
2023$4.90M+112.0%
2022$-40.88M-89.5%
2021$-21.57M-241.4%
2020$-6.32M-
2019$0.00-